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ABSTRACT 
Wound healing in skin is a complex process involving inflammatory responses, cell 
proliferation and migration, and extracellular matrix deposition. While, all-trans retinoic 
acid (ATRA) is believed to promote wound healing in skin, there are contradictory 
reports on its effect in both in vivo and in vitro studies. This study aimed at 
investigating the effects of ATRA at a concentration of 1μM (in DMSO) on cell 
migration and proliferation in ‘wound’ closure. A HaCaT and a HDF cell line as well as 
a co-culture of both cell lines were utilized. The cultures were maintained in DMEM 
supplemented with 5% fetal bovine serum incubated at 37ºC in a 5% CO2 in air 
humidified incubator. Scratch ‘wounding’ of the HaCaT culture and the co-culture 
were carried out prior to treatment with ATRA or its controls [DMSO (vehicle control) 
or DMEM (untreated control)]. 
ATRA did not have a significant effect on cell proliferation in either the HaCaT or HDF 
cultures or in the co-cultures. DMSO inhibited proliferation in the HDF cultures and in 
the co-cultures, while there was no effect on the HaCaT cultures. In addition, ATRA 
had no significant effect on ‘cell migration’ during ‘wound’ closure in both the HaCaT 
culture and the co-culture. However, DMSO appeared to be inhibitory to migration of 
cells in both cultures as there was a significant decrease in migration in cultures 
grown in DMSO when compared to ATRA treatment. The failure of ATRA to promote 
cell migration and proliferation during ‘wound’ closure in the HaCaT culture and the 
co-culture would seem to suggest that the activity of ATRA was compromised by 
DMSO. 
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CHAPTER ONE 
INTRODUCTION 
The skin is the largest organ by weight and one of the most complex organs of the 
human body. It is composed of the epidermis and the dermis. The epidermis is 
mainly made up of keratinocytes (Kanitakis, 2002). The other cells present in the 
epidermis are Langerhans cells, melanocytes, Merkel cells and lymphocytes 
(Kanitakis, 2002; Kerr, 2010). The keratinocytes are arranged in stratified layers 
named the stratum basale, stratum spinosum, stratum granulosum and stratum 
corneum from the basement membrane to the external surface of the epidermis 
(Singer and Clark, 1999; Kanitakis, 2002; Kerr, 2010). The keratinocytes migrate 
from the basal layer to the surface during which they differentiate and acquire the 
ability to produce keratin (Schaffer and Nanney, 1996, Kanitakis, 2002), flatten and 
are eventually shed from the surface of the skin (Kanitakis, 2002). 
The dermis is a vascularized, supportive and contractible layer of the skin 
(Kanitakis, 2002; Kerr, 2010). It has elastic connective tissue providing support and 
protection for the epidermis. The dermis contains several nerve fibres running 
through it and innervating the epidermis. Fibroblasts are the main cell type found in 
the dermis. Other cells found in the dermis include mast cells and macrophages 
(Kanitakis, 2002). In addition, the dermis also contains many fibres (mainly collagen 
types I and III) and ground substance (proteoglycans and glycoproteins) (Kanitakis, 
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2002) which are synthesized mainly by fibroblasts (Singer and Clark, 1999; 
Kanitakis, 2002; Metcalfe and Ferguson, 2006).  
The epidermal layer is separated from the dermis by a basement membrane at the 
epidermal-dermal junction (Kanitakis, 2002; Kerr, 2010). The basement membrane 
is a complex supportive tissue which is synthesized by both the keratinocytes and 
the dermal fibroblasts (Kanitakis, 2002). The basement membrane regulates the 
exchange of metabolic products between the layers of the skin as well as providing 
support for the migration of cells (lymphocytes, macrophages, fibroblasts) during 
wound healing (Kanitakis, 2002; Metcalfe and Ferguson, 2006).    
The human skin has several functions, most importantly, protection of the body from 
factors such as radiation, chemical burns, biological or physical injuries. Loss of 
function can, however, lead to disability or death (Singer and Clark, 1999). The 
vulnerability of the skin to injuries has led to many studies into the factors and 
mediators that influence the biological processes of wound healing in skin (Singer 
and Clark, 1999; Metcalfe and Ferguson, 2006; Sweitzer et al., 2006). 
Wound healing in skin is a complex and event-driven process which starts 
immediately after injury. The process of wound healing is initiated by the release of 
chemical signals usually from both the traumatized cells and the uninjured cells in 
the wound area (Metcalfe and Ferguson, 2006; Sweitzer et al., 2006). This initiates 
a well organized healing process comprising of inflammation, proliferation, migration 
and maturation (tissue remodeling) phases (Singer and Clark, 1999; Metcalfe and 
Ferguson, 2006; Sweitzer et al., 2006). These phases are influenced by complex 
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biological interactions between the cells present in the skin, the infiltrating cells into 
the wound region including blood cells and the extracellular matrix (Singer and 
Clark, 1999; Metcalfe and Ferguson, 2006; Sweitzer et al., 2006; Kondo, 2007).  
The inflammatory phase begins when a blood vessel is severed. The exudation of 
blood triggers a haemostatic response to halt blood loss. This is characterized by 
the formation of a platelet plug and vascular spasm (Singer and Clark, 1999; 
Metcalfe and Ferguson, 2006). Concurrently, an anti-inflammatory response is 
triggered which is characterized by the continuous infiltration of neutrophils and 
lymphocytes into the wound region in order to reduce inflammation (Chettibi and 
Ferguson, 1999; Singer and Clark, 1999; Kondo, 2007).  
Proliferation and migration phases as well as angiogenesis (Metcalfe and Ferguson, 
2006) overlap with inflammation and clot formation. These phases are characterized 
by the migration of keratinocytes and fibroblasts from the dermis and the infiltration 
of cells such as macrophages and neutrophils (Singer and Clark, 1999; Metcalfe 
and Ferguson, 2006). The proliferation of these cells and the biological interactions 
between them contribute to the regeneration of the epidermis and dermis (Singer 
and Clark, 1999; Metcalfe and Ferguson, 2006; Eming et. al., 2007; Kondo, 2007). 
The interactions between the cells resident in skin and the infiltrating cells trigger 
the release of cytokines and growth factors such as transforming growth factor-α 
(TGF- α), epidermal growth factor, keratinocyte growth factor and vascular 
endothelial growth factor (Singer and Clark, 1999; Metcalfe and Ferguson, 2006; 
Eming et. al., 2007; Kondo, 2007). 
4 
 
The final process of wound healing after the regeneration of the epidermis and the 
deposition of new granulation tissue in the dermis, is the maturation phase. This 
phase can take several months for completion in human skin (Singer and Clark, 
1999; Metcalfe and Ferguson, 2006). The maturation phase is characterized by a 
well organized relationship between the cells of the skin, the newly formed 
extracellular matrix and numerous secretions of cytokines (Chettibi and Ferguson, 
1999; Singer and Clark, 1999; Metcalfe and Ferguson, 2006). During this phase, 
fibroblasts differentiate into myofibroblasts which contribute to wound contraction 
and the formation of the extracellular matrix (Singer and Clark, 1999; Kanitakis, 
2002). Upon the regeneration of the epidermis and formation and contraction of 
formed extracellular matrix, the barrier properties of the skin are believed to be re-
established (Singer and Clark, 1999; Metcalfe and Ferguson, 2006). However, the 
repaired skin never reverts to the same tensile strength as the uninjured human skin 
(Singer and Clark, 1999). 
In addition to the influence of numerous cytokines, growth factors and mediators, 
external factors have been reported to affect the healing process as well. One such 
factor is retinoic acid. Retinoic acid belongs to the family of retinoids which are 
derived from vitamin A (Arukwe and Nordbo, 2008). Vitamin A is present in animal 
tissues as retinyl esters and retinoid-like retinol and its derivative (Fisher and 
Voorhees, 1996). Vitamin A is not synthesized by animals for their growth and 
development, but rather it is synthesized from dietary intake (Fisher and Voorhees, 
1996). Therefore, retinoids are usually referred to as ‘dietary hormones’ but lack 
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endogenic origin (Fisher and Voorhees, 1996; Simms and Ross, 2000; Bastien and 
Rochette-Egly, 2004; Arukwe and Nordbo, 2008).  
During digestion in vertebrates, the retinyl ester is converted to retinol which is later 
re-esterified to retinyl esters (Fisher and Voorhees, 1996; Harrison and Hussain, 
2001). The retinyl ester is released into the blood circulation and then transported to 
the liver or in a lesser amount, to adipose tissue for storage (Harrison and Hussain, 
2001). In the case of insufficient levels of retinol in the blood, the stored retinyl ester 
is converted back into retinol before being released into the blood plasma (Fisher 
and Voorhees, 1996).  
Retinol serves as a precursor for the biosynthesis of at least two important retinoids: 
retinal, a vision-related compound and retinoic acid, an active metabolite (Fisher 
and Voorhees, 1996; Dawson, 2000; Arukwe and Nordbo, 2008; Bremner and 
McCaffery, 2008). Retinoic acid adopts three primary isomers viz: all-trans retinoic 
acid (ATRA), 9-cis retinoic acid and 13-cis retinoic acid (Alsop et al., 2003; Marill et 
al., 2003). It is believed that most of the functions of vitamin A such as regulation of 
gene expression (Bremner and McCaffery, 2008), as well as differentiation of 
epidermal keratinocytes (Rendl et al., 2002; Eckhart et al., 2008) are performed by 
its active metabolic component, ATRA (Fisher and Voorhees, 1996; Arukwe and 
Nordbo, 2008). Interestingly, ATRA has also been found to modulate its own 
synthesis in the epidermis through its unique ability to regulate the enzymes 
responsible for ATRA production (Lee et al., 2009). 
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The ability of retinoic acid to regulate gene expression, differentiation and growth is 
dependent on retinoic acid binding to two nuclear hormone receptor families: the 
retinoic acid receptors (RAR) and retinoid X receptors (RXR) (Fisher and Voorhees, 
1996; Dawson, 2000; Ross et al., 2000; Bremner and McCaffery, 2008). In addition, 
a number of receptors known as ligand-receptors have also been implicated in the 
regulation of the retinoid response (Blumberg and Evans, 1998) and activation of 
genes responsible for cell morphogenesis, differentiation and proliferation (Alsop et 
al., 2003). 
Ulland et al. (1997) in a study on wound healing in male Sprague-Dawley rats with 
subcutaneous corticosteroid pellet-implants indicated that ATRA had a positive 
effect on impaired wounds by promoting the metabolism of depressed arginine to 
ornithine. The metabolism of depressed arginine to ornithine is important for 
reducing inflammation and in stimulating collagen accumulation and fibroplasias 
(Ulland et al., 1997). Similarly, Wicke et al. (2000) reported that ATRA reversed the 
non-healing effects of corticosteroid on dorsal skin wounds in the male Sprague-
Dawley rats. Paquette et al. (2001) reported that biopsies taken from non-healing 
leg ulcers of patients treated daily with ‘short-contact’ ATRA resulted in increased 
deposition of granulation tissue and deposition of collagen, as well as the 
appearance of new capillaries. 
Popp et al. (1995) reported that the skin biopsies from severely photo-damaged 
human-male forearms which were initially treated with topical ATRA cream (Retin 
A® cream) revealed a considerable network of capillaries, a compact stratum 
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corneum and increased dermal cells when compared to the control. There was an 
increase in wound closure and a facilitated repair of the epithelium from the start of 
the experiment in the treated group when compared to the control (Popp et al., 
1995). In a study of the effect of ATRA on full-thickness wounds in Wistar-Albino 
rats, Basak et al. (2002) reported a significant improvement in healing, 
characterized by increased synthesis of collagen, appearance of blood vessels and 
new granulation tissue around the wound regions.  
Retinoic acid has also been said to promote healing of impaired wounds (non-
healing wounds). Tom et al. (2005) in a study on healing in non-infected foot ulcers 
of diabetic male patients reported that topical application of an ATRA solution 
promoted healing of the ulcers. This was evidenced by a significant reduction in the 
size of wounds and mild wound healing which are common to diabetic patients such 
as delayed wound healing, peripheral vascular disease, decreased and disrupted 
collagen formation and most importantly chronic inflammation compared to the 
control (Tom et al., 2005). 
There are however several reports in the literature that contradict the beneficial 
effect of retinoic acid on wound healing. Hung et al. (1989) in a study of the effect of 
ATRA on pig skin found that daily treatment with ATRA for ten days prior to partial-
thickness wounding promoted healing of the wound. However, continued treatment 
with ATRA post wounding inhibited re-epithelization by increasing inflammation and 
dermal fibroplasia. Hung et al. (1989) suggested that the retardation of wound 
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healing in the pig model by ATRA treatment could have either been directly linked to 
the continuity of treatment or was the result of continuous dermal inflammation.  
In addition, Meuhlberger et al. (2005) in a study on sutured incision wounds on male 
CD-1 mice reported that topical application of ATRA for one week post wounding, 
significantly reduced the breaking strength of skin when compared to that of the 
vehicle control or untreated control groups. However, there was no significant 
difference in the breaking strength of the skin after two or three weeks of treatment 
post wounding (Meulhberger et al., 2005). Interestingly, Meulhberger et al. (2005) 
reported that treatment of wounds with ATRA for one week post wounding showed 
significant disturbance of the epidermal barrier as well as an increased 
accumulation of neutrophils and increased proliferation of fibroblasts when 
compared to that of the wounds treated with ATRA for two or three weeks post 
wounding. Disruption of the dermis was also enhanced in the wounds treated with 
ATRA for one week when compared to other treatment groups (Meulhberger et al., 
2005). Despite an increase in proliferation of the fibroblasts within the first week 
compared to the vehicle or untreated groups, the least amount of collagen was 
produced in the wounds treated with ATRA when compared to other treatment 
groups for the same treatment duration (Meulhberger et al., 2005). It was thus 
suggested that ATRA did not have an effect on unimpaired wounds but might rather 
be beneficial to patients with impaired vitamin A metabolism or patients with chronic 
non-healing wounds such as diabetes (Meulhberger et al., 2005). 
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Kitano et al. (2001) in a study on the effect of ATRA on wound healing in diabetic 
and in non-diabetic female mice reported that pretreatment for two days had 
minimal effect on the wound closure in normal (non-diabetic) mice, while there was 
a significant promotion of wound closure in the diabetic mice. It was suggested that 
ATRA may possess a unique ability to reverse the healing of impaired wounds in 
diabetic animals and that pretreatment may facilitate wound healing (Kitano et al., 
2001). 
The contradictions in the reports on the effect of ATRA on wound healing may be 
due to the differences in the animal models, experimental methods and conditions 
used in the studies. For example, several different animals are used including mice 
(Kitano et al., 2001; Meuhlberger et al., 2005); rats (Ulland et al., 1997; Basak et al., 
2002) pigs (Hung et al., 1989) and humans (Popp et al., 1995; Tom et al., 2005). 
Similarly, studies have used animal models with different disease states such as in 
diabetes mellitus (Kitano et al., 2001; Tom et al., 2005) or in conditions that impair 
healing such as the use of corticosteroid implants (Ulland et al., 1997). Despite the 
controversies, retinoic acid is approved by the U.S. Food and Drug Administration 
(FDA) and is still widely used for the treatment of acne and photo-aging (Lee et al., 
2005; Bremner and McCaffery, 2008) and as pretreatment against skin injuries 
before laser therapy (McDonald et al., 1999; Paquette et al., 2001). 
Interestingly, the contradictions in the effect of ATRA on wound healing are not only 
peculiar to in vivo studies but also to in vitro studies. Nelson and Balian (1984) 
reported a significant reduction in cell proliferation and in the synthesis of 
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procollagen by human dermal fibroblasts in a manner directly related to an increase 
in ATRA concentration from 10-11M to 10-6M. Kono et al. (1991) in a study on mouse 
3T3 fibroblasts embedded in a three-dimensional collagen gel reported that ATRA 
at concentrations of 1μM and 0.1μM resulted in increased contraction of the 
collagen gels when compared with the untreated control cultures. In the same study, 
it was reported that cell proliferation of the 3T3 fibroblasts in the collagen gel was 
significantly inhibited by ATRA at both concentrations (Kono et al., 1991). 
Interestingly, it was found that ATRA at a concentration of 1μM and 0.1μM had no 
effect on the contraction of the collagen gel and on cell proliferation of two 
transformed fibroblast cell lines (3T12-3 and 3T3-B-SV40) used in the same study 
(Kono et al., 1991). It was thus concluded that ATRA promoted contraction of 
collagen but it was uncertain whether ATRA promoted cell proliferation (Kono et al., 
1991). 
In addition to the reports on the effect of ATRA in in vitro studies, it has been found 
that ATRA at a concentration of 10µM has the ability to up-regulate the plasminogen 
activator system in normal human epidermal keratinocytes (Braungart et al., 2001). 
The ability of ATRA to promote the plasminogen activator system was suggested to 
be one of the mechanisms through which ATRA may promote re-epithelization 
during wound healing (Braungart et al., 2001). 
Considering the contradictions on the effect of ATRA on wound healing, it is 
possible that the bio-molecular mode of action of retinoic acid could be complex and 
not yet fully understood (Takami et al., 2005). In addition, ATRA is said to possess 
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pleiotrophic effects (Watson et al., 2004; Takami et al., 2005). One of the diverse, 
yet unknown, effects may possibly be indirect stimulation or release of biological 
mediators which could be responsible for promoting or inhibiting any of the phases 
of wound healing (Davies et al., 1988; Watson et al., 2004; Takami et al., 2005). A 
possible interaction of ATRA with other co-activators which are released by cells or 
whose release is regulated by ATRA could similarly have an influence on the 
retinoic acid receptors (Goyette et al., 2000). At the same time, the co-activators 
could augment or diminish the effects of ATRA (Lee et al., 2009). It is also possible 
that ATRA may elicit numerous biological functions that could be difficult to link to a 
specific gene transcription (Elder et al., 1991; Stoll and Elder, 1998). The possible 
interference of co-activators or the diverse effect of ATRA on biological functions 
could be the reasons for the contradictions in the reports on the effect of ATRA.  
In addition, it has been reported that the in vitro effect of ATRA on the differentiation 
of keratinocytes was directly opposite to the in vivo effect (Fisher and Voorhees, 
1996). To re-emphasize, differentiation is important during the maturation phase of 
wound healing in which the keratinocyte acquires the ability to produce keratin 
(Schaffer and Nanney, 1996). Fisher and Voorhees (1996) compared reports on the 
effect of ATRA on keratinocytes and concluded that ATRA promoted proliferation of 
keratinocytes in the basal layer of the epidermis in vivo. Following this, the basal 
cells migrated to the suprabasal layer before terminally differentiating and losing 
their ability to proliferate. In vitro however, differentiation of the keratinocytes 
resulted in the arrest of cell proliferation (Fisher and Voorhees, 1996) or the cells 
undergo functional differentiation characterized by the expression of markers for 
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differentiation (Jetten, 1990; Fisher and Voorhees, 1996). ATRA however, had a 
more significant effect in inhibiting the expression of markers for differentiation in 
keratinocytes than preventing the arrest of proliferation of keratinocytes (Jetten, 
1990; Fisher and Voorhees, 1996).  
ATRA inhibits the expression of markers of differentiation in keratinocytes, in vitro, 
at a concentration of 1μM (Fisher and Voorhees, 1996; Rendl et al., 2002; Eckhart 
et al., 2008; Lee et al., 2009). For this reason, Eckhart et al. (2008) regarded a 
concentration of 1μM of ATRA as a ‘physiologically relevant concentration’. This is 
thus the concentration of ATRA frequently utilized in several studies on skin cell 
types (Tsou et al., 1994; Weninger et al., 1998; Diaz et al., 2000; Lee et al., 2009). 
The present study utilized an in vitro situation to investigate the effects of ATRA on 
cell migration and proliferation during wound healing. Two individual cell lines 
derived from human skin, an immortalized non-tumorigenic human keratinocyte 
(HaCaT) cell line (Boukamp et al., 1988) and the human dermal fibroblast (HDF) cell 
line were utilized. It was envisaged that an in vitro situation would be more effective 
in monitoring the effects of ATRA on wound healing compared to the use of an in 
vivo condition, as other biological factors (co-activators) could be present in an in 
vivo situation. 
In addition, wound healing capabilities of ATRA were investigated on an in vitro co-
culture system of HaCaT and HDF cell lines which was used as a mimic of intact 
skin. It was envisaged that the biological functions during wound healing in skin as 
they relate to or are affected by ATRA could be monitored more effectively in an in 
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vitro condition using a co-culture (Maas-Szabowski et al., 2004). It was envisaged 
also that the co-culture system could possibly provide data on the effect of ATRA on 
wound healing which could be comparable to ‘intact’ skin as described in the 
literature.  
It is worthy to state that no completely functional in vitro skin model that truly 
represents the anatomical, physiological and biological stability of skin has been 
reported (Lim et al., 2002; Suhonen et al., 2003; Maas-Szabowski et al., 2004; 
Metcalfe and Ferguson, 2006). Boyce and Waden (2002) in a review of principles 
and practices for the treatment of wounds with cultured skin substitutes, 
emphasized the importance of a complete ‘recapitulation of ontogenesis’ of skin. 
While complete regeneration is important for a functional skin, this recreation is yet 
to be achieved under in vitro conditions (Boyce and Waden, 2002). In addition, 
vascularization has never been achieved in an in vitro skin model (Metcalfe and 
Ferguson, 2006). Thus, an organotypic culture with a developed permeability barrier 
cannot be compared to a more complex and highly interactive basement membrane 
as found in healthy skin (Lim et al., 2002; Suhonen et al., 2003; Maas-Szabowski et 
al., 2004; Metcalfe and Ferguson, 2006). Instead, attempts at developing a 
functional skin are directed towards mimicking the conditions found in normal skin, 
such as the presence of an extracellular matrix and the presence of two or more 
types of skin cells which basically mimic the cellular interactions of skin (Lim et al., 
2002; Suhonen et al., 2003; Metcalfe and Ferguson, 2006). 
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In vitro studies of the skin have been attempted with the use of the different types of 
skin cells cultured alone, for example: fibroblasts (Lee et al., 1998; Ohgoda et al., 
1998; Dewor et al., 2007) or keratinocytes (Weninger et al., 1998; Rendl et al., 
2002; Eckhart et al., 2008). In addition, in vitro studies of skin have been conducted 
on co-cultures of keratinocytes and fibroblasts without an extracellular matrix (Lee et 
al., 2006) or with an extracellular matrix (Maas-Szabowski et al., 2004; Lee et al., 
2005). There are reports in the literature that the dermis of skin consists 
predominantly of fibroblasts which are responsible for synthesizing collagen fibres 
for repair of the dermis (Singer and Clark, 1999; Moulin et al., 2000; Kanitakis, 
2002; Lee et al., 2006; Metcalfe and Ferguson, 2006) as well as secreting growth 
factors which are stimulatory to epithelial proliferation and cell motility (Lawrence 
and Diegelmann, 1994; Goulet et al., 1996; Singer and Clark, 1999; Lee et al., 
2006) during wound healing. 
In order to assess the effect of ATRA on ‘wound’ closure in vitro, the study aimed to: 
i. determine the effect of ATRA on cell proliferation of a HaCaT cell line and a 
HDF cell line 
ii. evaluate the effect of ATRA on cell migration during ‘wound’ closure in the 
HaCaT cultures and in the co-cultures of HaCaT and HDF cell lines, and 
iii. investigate the effect of ATRA on cell proliferation during ‘wound’ closure in 
the HaCaT cultures and in the co-cultures of HaCaT and HDF cell lines. 
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CHAPTER TWO 
MATERIALS AND METHODS 
2.1 Culturing of cell lines 
Two cell lines were used in the experiments: 
a. an immortalized non-tumorigenic human keratinocyte (HaCaT) cell line 
derived from normal adult human trunk skin (Boukamp et al., 1988). These 
cells are capable of stratification (Maas-Szabowski, et al., 2004; Deyrieux 
and Wilson, 2007). The cell line was donated by the German Cancer 
Research Centre. The HaCaT cell line was seeded into a 75 ml Nunc® 
culture flask and maintained in Dulbecco’s Modified Eagle’s medium (DMEM) 
(Lonza, South Africa) supplemented with 10% fetal bovine serum (FBS) 
(Lonza, South Africa) and a 0.1% mixture of streptomycin and penicillin in 
phosphate buffered saline (PBS) (Sigma, South Africa) at 37ºC in a 5% CO2 
in air humidified incubator. The culture medium was changed every two to 
three days as necessary.  
b. a human dermal fibroblast (HDF) cell line derived from adult skin was 
obtained from American Type Culture Collection, ATCC (CCD-1140Sk). The 
HDF cell line was seeded into a 25 ml Nunc® culture flask. The cultures of the 
HDF cell line were maintained in Iscove’s Modified Dulbecco’s Medium 
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(IMDM) (Lonza, South Africa) supplemented with 10% FBS and a 0.1% 
mixture of streptomycin and penicillin in PBS at 37ºC in a 5% CO2 in air 
humidified incubator. The culture medium was changed every four to five 
days as required.  
The cultures of the HaCaT and the HDF cell lines were allowed to reach 80-90% 
confluence before sub-culturing. Unlike the HaCaT cell line which is theoretically  
capable of unlimited growth and number of passages, the HDF cell line is only 
capable of undergoing about 42 population doublings (ATCC technical Bulletin, 
2007) without phenotypic changes. The HDF cell line was supplied at passage two 
and in this study, was used at the fourth to seventh passage. 
2.2 All-trans retinoic acid (ATRA) 
ATRA (C20H26O2) is a yellow powder (molecular weight of 300.44) supplied in a light 
protected vial (Sigma, South Africa). It was stored at -20ºC. According to the 
accompanying Sigma product information sheet (Product no: R2625), the ATRA 
powder is virtually insoluble in water, only slightly soluble in alcohol but highly 
soluble in dimethylsulphoxide (DMSO). DMSO is thus often used as a diluent for 
ATRA (Muehlberger et al., 2005; Bianchi et al., 2008; Eckhart, et al., 2008). For this 
study, a stock solution of ATRA (0.0667M) was obtained by dissolving 100mg ATRA 
powder in 5ml 100% DMSO (Appendix I). The ATRA stock solution was stored in a 
light protected vial at -4ºC because of its high sensitivity to ultra-violet light, heat and 
air, especially when in solution (Sigma product information, product no R2625). 
Serial dilutions of ATRA were prepared fresh under subdued light.  
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In the present study, ATRA at a concentration of 1μM was used in all the 
experiments as it is regarded as a ‘physiologically relevant’ concentration at which 
terminal differentiation of keratinocytes is inhibited (Jetten, 1990; Fisher and 
Voorhees, 1996; Rendl et al., 2002; Eckhart et al., 2008). This concentration is also 
frequently utilized in several studies on skin cell types such as keratinocytes, 
fibroblasts and melanocytes (Tsou et al., 1994; Weninger et al., 1998; Diaz et al., 
2000; Lee et al., 2009).  The concentration of DMSO (vehicle control) used was 
0.0015% which is equivalent to the DMSO concentration in 1μM ATRA (Appendix I). 
In this study, except where stated otherwise, ‘ATRA treatment’ refers to 1μM ATRA 
(reconstituted in DMSO) in DMEM. Controls utilizing DMSO in DMEM or DMEM 
alone will be referred to as ‘vehicle control’ or ‘untreated control’ respectively. All the 
medium for the ATRA treatment, vehicle control and the untreated control were 
supplemented with 10% FBS. 
2.3 Cell proliferation assay 
The cell proliferative effect of ATRA at a concentration of 1μM was investigated on 
the HaCaT and the HDF cell lines as described in section 2.3.1.   
2.3.1 Preparation of cultures for ATRA treatment and evaluation of cell 
proliferative activity 
In this analysis, the culturing and the treatment of the HaCaT cell line was 
performed in DMEM while culturing and treatment of the HDF cell line was done in 
IMDM. The experiments utilizing each of these two cell lines were performed in 
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separate 96-well microplates in triplicate. For each of these cell lines, one 96-well 
microplate was prepared for the ATRA treatment and the vehicle control. The wells 
at the periphery of the 96-well microplate contained only sterile PBS in order to 
prevent drying out of the content of the wells in the plate. The HaCaT or HDF cells 
were counted using a haemocytometer (Appendix II) and seeded at a concentration 
of 1X104 cells per ml per well into all wells of the plate except for one column which 
served as the blank for spectrophotometry. The blank served as the control for the 
colour intensity of the medium used and contained only media (DMEM or IMDM 
supplemented with 10% FBS) and no cells. 
The medium for the untreated control cultures was DMEM or IMDM alone. The 
medium for the treated cultures was ATRA at a concentration of 1µM (Appendix I) 
while in the medium for the vehicle control cultures contained 0.0015% DMSO in 
DMEM or IMDM. The solution in each of the wells in the microplate had a final 
volume of 100µl. The cultures were incubated at 37ºC in a 5% CO2 in air humidified 
incubator for 24 hours. The experiment was repeated and thus the total numbers of 
samples for the ATRA treatment, the vehicle control and the untreated control 
(DMEM or IMDM alone) were six samples each.  
2.3.2 Evaluation of cell proliferation using the CellTiter 96 Aqueous® reagent 
CellTiter 96® aqueous reagent is a ‘one solution’ reagent used as a cell proliferation 
assay. It utilizes a colorimetric method for determining the number of viable 
proliferating cells or of evaluating the cytotoxicity of agents in monolayer cultures 
(Promega technical bulletin: Part no TB245). The CellTiter 96® aqueous reagent 
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contains a tetrazolium compound [3-(4,5-dimethylthiazol-2-yl)-5-(3-
carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium] and an electron coupling 
reagent, phenazine ethosulfate (PES). The PES enhances chemical stability by 
allowing it to form a stable solution with the tetrazolium compound (Promega 
technical bulletin: Part no TB245). This tetrazolium compound is biologically 
reduced by proliferating cells into a coloured soluble formazan product in tissue 
culture media (Promega technical bulletin: Part no TB245). 
After treating the cells for 24 hours as described in section 2.3.1, 20µl of CellTiter 96 
Aqueous® reagent was added to each well. The cultures were incubated at 37ºC in 
a 5% CO2 in air humidified incubator for three hours. According to the 
manufacturer’s information, the colour intensity of the solution in each well should 
indicate the amount of soluble formazan product produced by the cellular reduction 
of the tetrazolium compound. Following incubation, absorbance was measured at 
490nm (Promega technical bulletin: Part no TB245) with an Anthos 2010 
spectrophotometer. 
The average absorbance value of the blank control was subtracted from the 
individual absorbance readings. A graph of the absorbance readings, which gives 
an indication of cell proliferation expressed as a percentage of the untreated control, 
for both the HaCaT and the HDF cell line was plotted against the ATRA treatment 
and the vehicle control. Evaluation of a statistically significant difference in cell 
proliferation in the three treatment groups (ATRA treatment, vehicle control and 
untreated control) was performed using a Kruskal-Wallis one way analysis of 
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variance (ANOVA) test (a non-parametric test for three or more independent 
samples) at a significant level of 5%. 
2.4. Scratch assay 
In an in-vitro study of the factors influencing the healing of a wound, a scratch assay 
is often used (Conant et al., 2010). The effect of a therapeutic agent on cell motility 
or cell proliferation, as well as molecular activities such as cell signaling, the 
inflammatory response and tissue remodeling, which are associated with wound 
healing, can be monitored using a scratch assay (Conant et al., 2010). The ‘wound’ 
is made by drawing the tip of a pipette or pin through a confluent culture (Buth et al., 
2007; Dewor et al., 2007; Cheng et al., 2008; Fronza et al., 2009). This deliberate 
damage to the monolayer of a confluent cell culture leaves a cell-free region 
(‘wound’) within the culture (Conant et al., 2010). The ‘wound’ that is created by 
using this method mimics to a certain extent, the biological phenomena of an injury 
to normal human skin (Yarrow et al., 2004; Conant et al., 2010). 
2.4.1 Preparation of HaCaT cultures for scratch ‘wound’ assay and ATRA 
treatment 
The HaCaT cell line was seeded at a concentration of 1X106 cells per ml in a 6-well 
culture plate. Two 6-well culture plates were designated for each of the three 
treatment groups (ATRA treatment, vehicle control and untreated control). The 
cultures were incubated at 37ºC in a 5% CO2 in air humidified incubator until they 
had reached 100% confluence usually in five days following seeding. Prior to 
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seeding of the cells, two parallel lines (5mm apart) were drawn on the undersurface 
of the plastic well at the centre of the wells using a waterproof marker (Liang et al., 
2007). This was used to demarcate the region at which repeated photographs would 
be taken at different time periods.  
On reaching confluence, the wells were washed with calcium and magnesium-free 
PBS (CMF-PBS) (Appendix III). The CMF-PBS was used to reduce cell membrane 
adhesion (Buth et al., 2007). After the CMF-PBS was aspirated, the cultures were 
‘wounded’ by making a scratch at right angles to the marked parallel lines in each 
well with the tip of a 200µl pipette tip held in an upright position. The wells were 
washed again after scratching with CMF-PBS in order to remove dislodged cells. 
Then, 2ml of either 1µM ATRA treated medium (n=12), untreated control medium 
(n=12) or vehicle control medium (n=12) were added into the respective wells of the 
culture plates.  
2.4.2 Preparation of co-cultures for scratch ‘wound’ assay and ATRA 
treatment 
Two 6-well culture plates were designated for each of the three treatment groups 
(ATRA treatment, vehicle control and untreated control). Prior to seeding of the 
cells, the demarcated region on the 6-well culture plates were prepared as 
described in section 2.4.1. Initially, the HDF cell line was seeded at a concentration 
of 1 X 104 cells per ml of IMDM supplemented with 10% FBS into a 6-well culture 
plate and incubated at 37ºC in a 5% CO2 in air humidified incubator for five days. 
After five days, the medium was aspirated and then the HaCaT cells, at a 
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concentration of 1 X 106 cells per ml of DMEM supplemented with 10% FBS, was 
carefully seeded on to the HDF cultures and then incubated at 37ºC in a 5% CO2 in 
air humidified incubator until both cell lines had reached 100% confluence. On 
reaching confluence, the co-cultures were ‘wounded’ as described in section 2.4.1. 
Then, 2ml of solution of either the 1µM ATRA treated medium (n=12), the vehicle 
control medium (n=12) or the untreated control medium (n=12) was added into the 
respective designated culture plates.  
2.4.3. Analysis of ‘wound’ closures in the HaCaT cells and in the co-cultures  
Following ‘wounding’, the demarcated region in each well was immediately 
photographed on an inverted phase contrast microscope with an attached Olympus 
digital camera. A diagrammatic representation of the wound region is depicted in 
Figure 1a. All the photographs for the scratch-wound analysis were taken at the 
same magnification, light intensity, camera resolution and camera zoom. The time 
period immediately after the scratching was designated as “0”-hour of wound 
closure. The photographs of the same region of each culture were taken at 0, 2, 4, 
6, 8, 10 and 24 hours following ‘wounding’.  
The images thus obtained were analyzed by overlaying with a grid from ImageJ 
1.42q software from National Institutes of Health (NIH) in the United States. The 
width of the scratch region was measured at five different regions along the length 
of the scratch as illustrated in figure 1b. These measurements were taken by tracing 
the margins of the scratch on the y-coordinate of the grid. In this way, the individual 
width of the cell-free region (‘wound’ closure) of the scratch in each of the cultures 
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was obtained (Appendix VI). The average width of the scratch at time 0 hour (X) and 
at each of experiment time points, t (2, 4, 6, 8, 10 and 24 hours) (Y) was also 
determined for each experimental group. The change in the width of the scratch was 
then calculated and compared (i.e. X-Y), as illustrated in Figure 1b, for each 
experimental group for both the HaCaT cell monolayers and the co-cultures. It is 
important to note that the actual margin of scratch was not straight (Fig. 1b). The 
change in the width of the scratch was used as an indication of ‘cell migration’ after 
the start of experiment under the different treatment regimes (Dewor et al., 2007). 
However, the measurements actually reflect ‘wound’ closure which may be a 
combination of cell proliferation and migration (Dewor et al., 2007). 
A statistically significant difference in ‘wound’ closure in the three treatment groups 
(ATRA treatment, vehicle control and untreated control) at different time periods was 
evaluated using a Kruskal-Wallis one-way ANOVA test (a non-parametric test for 
three or more independent samples) at a significant level of 5%. A Mann-Whitney (a 
non-parametric test for two independent samples) was used to evaluate a statistical 
difference in wound closure between the HaCaT cultures and the co-cultures for 
either ATRA treatment or vehicle control or untreated control. 
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Figure 1: a) Diagrammatic illustrations of the scratch region at the time of scratching 
(0 hour) and different time periods (t hours) illustrating how the measurements of 
the width of the scratch at five different regions of the ‘wound’ were taken; and b) a 
representative photomicrograph of the scratch region at 8 hours following scratching 
illustrating the irregular margin of the scratch region. Phase contrast microscopy X4. 
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2.5 Ki-67 immunolabelling assays 
Ki-67, a non-histone protein (395 kDa), is a nuclear antigen that is exclusively 
expressed in the proliferative stages (late G1, S1, G2 and M phases) of the cell 
cycle (Fisher et al., 2002; Potemski et al., 2006; Faratzis et al., 2009). Ki-67 gene is 
located on chromosome 10. There is down-regulation of Ki-67 protein when cells 
exit the cell cycle which makes Ki-67 protein an excellent marker for proliferating 
cells (Fisher et al., 2002; Potemski et al., 2006; Faratzis et al., 2009). For this 
reason, actively proliferating cells are immunolabelled or identified usually by their 
characteristic dark staining of the nucleus when a monoclonal antibody to Ki-67 is 
utilized (Fisher et al., 2002). 
2.5.1 Preparation of HaCaT cells for immunocytochemistry 
Prior to the seeding of the HaCaT cell line, sterilized glass cover slip (22mm X 
22mm) was placed in each of the wells of a 6-well culture plate. The cover slips 
were rinsed briefly with sterile PBS before the cells were seeded on to them at a 
concentration of 1X106 cells per ml. A 6-well culture plate was designated each for 0 
and 24 hour treatment durations. Only two wells in the 6-well culture plate 
designated for 0 hour contained the cultured HaCaT cells while the other wells 
contained PBS alone. For the culture plate designated for 24 hour treatment 
duration, two wells of the 6-well culture plate were assigned for each of the three 
treatment groups (ATRA treatment, vehicle control and untreated control). The 
experiment was repeated once. After seeding, the cells were incubated at 37ºC in a 
5% CO2 in air humidified incubator until they had reached 100% confluence. 
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On reaching confluence, the HaCaT cultures were ‘wounded’ as described in 
section 2.4.1. After ‘wounding’, the cells in the wells of the culture plate designated 
for 0 hour were immediately rinsed with PBS and the cells on the cover slips were 
fixed in 3ml of 3% formaldehyde in PBS. Into the wells of culture plate designated 
for 24 hour, 2 ml of solution of either the 1µM ATRA treated medium (n=4) or the 
untreated control medium (n=4) or the vehicle control medium (n=4) was added into 
each well. 
At 24 hours, the liquid content of the wells was aspirated and 3ml of 3% 
formaldehyde in PBS was added into each well. The fixation was performed for 24 
hours before processing for immunocytochemistry as described in section 2.5.3.  
2.5.2 Preparation of cells in the co-cultures of HaCaT and HDF cells for 
immunocytochemistry  
A 6-well culture plate containing sterilized cover slips was designated each for 0 and 
24 hour treatment durations as described in section 2.5.1. The HDF cells were 
initially seeded on to the sterilized cover slips at a concentration of 1 X 104 cells per 
ml of IMDM supplemented in 10% FBS and incubated at 37ºC in a 5% CO2 in air 
humidified incubator for five days. Following this, the medium was aspirated and 
then the HaCaT cells, at a concentration of 1X106 cells per ml of DMEM 
supplemented with 10% FBS, were carefully seeded on to the HDF cell line. The co-
cultures of HaCaT and HDF cells were further incubated at 37ºC in a 5% CO2 in air 
humidified incubator until they had reached 100% confluence.  
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After reaching confluence, the cells in the culture plates designated for the 0 and 24 
hour were wounded as described in section 2.5.1. After ‘wounding’, the cells in the 
wells of the culture plate designated for 0 hour were immediately washed in sterile 
PBS before fixing in 3ml of 3% formaldehyde in PBS. Then, 2ml of solution of either 
the 1μM ATRA treated medium (n=4), the vehicle control medium (n=4) or the 
untreated control medium (n=4) was added into each well of the culture plate. 
Following 24 hours of incubation, the liquid content of the wells was removed and 
3ml of 3% formaldehyde in PBS was added to each well in order to fix the cells. The 
cells were fixed for 24 hours before processing for immunocytochemistry as 
described in section 2.5.3. 
2.5.3 Ki-67 immunolabelling using the Avidin-Biotin method 
The Ki-67 immunolabelling for the HaCaT cell line and the co-cultures were carried 
out by adding the different reagents for immunocytochemistry (Appendix IV) directly 
into each of the wells containing the fixed cultures. After fixing for 24 hours, the 
fixative was aspirated and the wells were washed once with Tris-Buffered Saline 
(TBS). The TBS was completely aspirated and the cells permeabilized with 0.2% 
Triton X-100 (from stock of 20% Triton in PBS) for five minutes at room temperature 
before quenching in fresh 0.1% sodium borohydride in TBS for another five minutes. 
The solution was replaced with TBS before 1ml of blocking buffer [5.5% normal goat 
serum in TBS/Triton (0.1% Triton X-100 in TBS)] was added to each well for one 
hour at room temperature. The cells were washed once again with 1ml TBS and 
then aspirated. The cells were incubated overnight at 4ºC with a mouse monoclonal 
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anti-proliferating cell protein Ki-67 primary antibody (Sigma, South Africa) in 3% 
bovine serum albumin in TBS (1:800). In the wells for the negative control, the Ki-67 
antibody was omitted and TBS alone was added. 
After the overnight incubation, the cells were washed twice for five minutes each 
with 1ml TBS/Triton and then washed once with TBS. The cells were subsequently 
incubated with a polyclonal goat anti-mouse biotinylated secondary antibody (Dako, 
South Africa) diluted in 3% bovine serum albumin in TBS (1:500) for one hour at 
room temperature. This solution was aspirated, and the cells washed three times for 
five minutes each with 1ml TBS/Triton and then once for five minutes with 1ml TBS. 
Following this, the cultures were incubated for exactly 30 minutes in 0.6% hydrogen 
peroxide in TBS at room temperature. The solution was aspirated, and the cells 
were once again washed three times for five minutes each with 1ml TBS/Triton. 
Further washing in one change of TBS was carried out before the cells were 
incubated for one hour with 800µl Vectastain ABC Kit (Dako, South Africa) at room 
temperature.  
The solution was completely aspirated, and the cells washed twice for five minutes 
each with 1ml TBS. Then, 1ml diaminobenzidine tetrahydrochloride (DAB) reagent 
(Sigma, South Africa) was added into each well. This reaction was monitored using 
a microscope in order to reduce background effect. The reaction was terminated by 
quickly adding exactly 1ml distilled H2O into each well. This solution was aspirated 
and the cells washed once again with 1ml distilled H2O. The cover slips were dipped 
twice each in a graded series of alcohol and then in two changes of xylene before 
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being mounted with Entellan (Merck, South Africa) on to glass slides (1mm X 76mm 
X 26mm).  
2.5.4 Estimation of the number of Ki-67 positively immunolabelled nuclei 
around the ‘wound’ regions  
The estimation of the number of the Ki-67 positively immunolabelled nuclei in both 
the HaCaT cultures and the co-cultures for 0 hour and 24 hour (for the ATRA 
treatment, untreated control and vehicle control) treatment durations was 
determined by counting these actively proliferating nuclei located around the 
‘wound’ region (Dewor et al., 2007). For ease of counting and validation of the 
counted cells, five photographs were taken in series at every 3-mm interval around 
the margin of the ‘wound’ region with X10 objective of a Zeiss inverted microscope 
attached to a digital camera. Thus the area of field was standard in all the 
photographed regions. The regular interval was achieved by moving the calibrated 
stage of the microscope.  
A total of 10 photographs (five photographs from each side of the wound) were 
taken per culture. The Ki-67 positively immunolabelled nuclei on each of the 
photographs were manually counted with the use of a grid and a cell counter using 
the ImageJ software from the NIH in the United States. The actively proliferating 
nuclei in the photographs were counted again after a two week interval to obviate 
bias. 
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The estimated number of the Ki-67 positively immunolabelled nuclei at 0 hour and 
24 hours (for the ATRA treatment, the untreated control and the vehicle control) for 
both the HaCaT cultures and the co-culture were compared. Initially, a Mann-
Whitney test (a non-parametric test for two independent samples) was used to 
evaluate the significant difference between the two independent counts of the Ki-67 
positively immunolabelled nuclei for each sample. Then, a Kruskal-Wallis one way 
ANOVA test (a non-parametric test for three or more independent samples) was 
performed to evaluate whether a statistically significant difference occurred in the 
number of actively proliferating cells between the groups of data (0 hour and 24 
hours: ATRA treatment, untreated control, vehicle control). A significance level of 
5% was used as an indicator of significance difference for both statistical analyses.    
 
 
 
 
 
 
31 
 
 
CHAPTER THREE 
RESULTS 
3.1 General observations of the cultures 
The HaCaT cells were polygonal in shape (Fig. 2a). They attached within 24 hours 
of seeding. Similar to the HaCaT cells, the HDF cells also attached within 24 hours. 
The HDF cells were spindle shaped and did not exhibit any obvious characteristics 
of senescence such as increased cytoplasmic processes and slowed or halted cell 
growth (Fig. 2b).  
In the co-cultures of the HaCaT and HDF cell lines, the HDF cells were visible prior 
to confluence (Fig. 3 and 4a). The co-cultures usually reached confluence on day 
five after seeding the HaCaT cells on to the cultures of HDF cells. However, when 
the HaCaT cells or the HDF cells were cultured alone, confluence was usually 
reached at day five and day eight respectively after seeding. In the confluent co-
culture, the HaCaT cells grew over the HDF cells and thus the HDF cells were no 
longer easily visible (Fig. 4b).   
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a) 
 
b) 
 
Figure 2: Representative photomicrographs of cultures of a) HaCaT and b) HDF cell 
lines after 72 hours of seeding. Phase contrast microscopy, X10. 
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a) 
 
b) 
 
Figure 3: Representative photomicrographs of a co-culture of HaCaT and HDF cells 
on the a) first and b) second day after seeding. Phase contrast microscopy, X10. 
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a) 
 
b) 
 
Figure 4: Representative photomicrographs of a co-culture of HaCaT and HDF cells 
on the a) fourth day after seeding and b) at confluence in which the HDF cells were 
no longer easily visible in the co-culture. Phase contrast microscopy, X10 
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3.2 Effect of ATRA on proliferation of the HaCaT and the HDF cell lines 
Cell proliferation analysis using the colorimetric assay on the HaCaT cell cultures 
showed no significant difference in cell proliferation of the cultures treated with 1μM 
ATRA compared to the untreated control cultures (p=0.2980) or the vehicle control 
cultures (p=0.1735) (Fig. 5). There was similarly no significant difference in cell 
proliferation when the vehicle control cultures were compared with the untreated 
control cultures (p=0.8102) (Appendix V).  
In the HDF cell cultures (Fig. 6), cell proliferation was decreased in the cultures 
treated with ATRA but this decrease was not significantly different when compared 
with the untreated controls (p=0.1495). However, both the HDF cultures treated with 
ATRA and the untreated control cultures showed a significant increase in cell 
proliferation when compared to the vehicle control cultures (p=0.0051 and p=0.0051 
respectively).  
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Figure 5: A graphical illustration of the relationships of ATRA treatment, DMSO 
(vehicle control) and DMEM (untreated control) on cell proliferation of the HaCaT 
cell cultures. There was no statistically significant difference in cell proliferation 
when the three treatment groups were compared (n=6).  
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Figure 6: A graphical illustration of the relationships of ATRA treatment, DMSO 
(vehicle control) and DMEM (untreated control) on cell proliferation of the HDF cell 
cultures. There was a significant difference in cell proliferation when ATRA 
treatment and vehicle control or vehicle control and untreated controls were 
compared (n=6, **p<0.01). 
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3.3 General observations in the ‘wounded’ cultures 
The score regions of the HaCaT cultures and the co-cultures were relatively clear of 
any cellular debris, following scratching. Score closure in the HaCaT cultures and in 
the co-cultures occurred progressively. The closure of the ‘wound’ appeared to be 
the result of migration of cells at the score edge and the proliferation of cells around 
the ‘wound’ region (Fig. 7). Representative photomicrographs of the ‘wounded’ 
regions in the HaCaT cultures and the co-cultures for the ATRA treatment, the 
untreated control and the vehicle control at different time periods are shown in 
figures 8 – 13. 
 
 
 
 
 
 
 
 
39 
 
  a) 
 
  b) 
 
Figure 7: Representative photomicrographs showing ‘wound’ closures in a HaCaT 
culture immunolabelled with Ki-67 primary antibody. Phase contrast microscopy, a) 
X10 b) X40. 
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Figure 8: Representative photomicrographs of the same ‘wounded’ region of a 
HaCaT culture with ATRA treatment at different time periods. Phase contrast 
microscopy, X4. 
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Figure 9: Representative photomicrographs of the same ‘wounded’ region of an 
untreated HaCaT culture at different time periods. Phase contrast microscopy, X4. 
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Figure 10: Representative photomicrographs of the same ‘wounded’ region of a 
HaCaT culture grown in vehicle control medium at different time periods. Phase 
contrast microscopy, X4. 
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Figure 11: Representative photomicrographs of the same ‘wounded’ region of a co-
culture of HaCaT and HDF cells with ATRA treatment at different time periods. 
Phase contrast microscopy, X4. 
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Figure 12: Representative photomicrographs of the same ‘wounded’ region of an 
untreated co-culture of HaCaT and HDF cells at different time periods. Phase 
contrast microscopy, X4. 
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Figure 13: Representative photomicrographs of the same ‘wounded’ region of a co-
culture of HaCaT and HDF cells grown in vehicle control medium at different time 
periods. Phase contrast microscopy, X4. 
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3.4 Effect of ATRA on ‘wound’ closure 
HaCaT cultures 
The ‘wounds’ treated with ATRA were reduced in width compared to those in the 
untreated control cultures and the vehicle control cultures at the same time periods 
i.e. 6 to 24 hours, while ‘wound’ closure was increased in the untreated control 
cultures compared to the vehicle control cultures (Fig. 14). There was no statistically 
significant difference in score closure when the cultures treated with ATRA or the 
untreated controls or the vehicle controls were compared at different time periods 
after the start of score closure (Appendix VI). However by 10 hours and 24 hours 
respectively (Fig. 14), ‘wound’ closure was significantly increased in the cultures 
treated with ATRA when compared to the vehicle control cultures (10 hours: 
p=0.0166; 24 hours: p=0.0404). 
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Figure 14: A graphical illustration of the effects of ATRA treatment, DMSO (vehicle 
control) and DMEM (untreated control) on ‘wound’ closure in the HaCaT cultures at 
different time periods. By 10 and 24 hours after ‘wounding’, ‘wound’ closure was 
significantly different when the ATRA treatment and the vehicle control were 
compared (n=12, *p<0.05). 
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Co-cultures 
Similar to ‘wound’ closure in the HaCaT cultures, the ‘wounds’ treated with ATRA 
were reduced in width compared to those in the untreated control cultures and the 
vehicle control cultures at the same time periods i.e. 4 to 24 hours (Fig. 15). At the 
different time periods after the start of score closure, there was no statistically 
significant difference in ‘wound’ closure when the co-cultures with ATRA treatment 
or the untreated co-cultures or the co-cultures grown in the vehicle control medium 
were compared (Appendix VI). By 24 hours however, score closure was significantly 
increased in the co-cultures treated with ATRA when compared to the co-cultures 
grown in vehicle control medium (p=0.0226). 
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Figure 15: A graphical illustration of the effects of ATRA treatment, DMSO (vehicle 
control) and DMEM (untreated control) on ‘wound’ closure in the co-cultures of 
HaCaT and HDF cells at different time periods. By 24 hours after ‘wounding’, 
‘wound’ closure was significantly different when the ATRA treatment and the vehicle 
control were compared (n=12, *p<0.05). 
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3.4.1 Comparison of ‘wound’ closure in the HaCaT cultures with that in the co-
cultures 
In all the treatment groups (ATRA treatment, untreated control or vehicle control), 
‘wound’ closure appeared to be more pronounced in the HaCaT cultures than in the 
co-cultures. In the cultures treated with ATRA (Fig. 16), score closure was 
significantly increased in the HaCaT cultures when compared to the co-cultures 
(p=0.0173) by 10 hours post-wounding. By 24 hours post-wounding however, there 
was a slight increase in score closure in the HaCaT cultures, which was not 
significantly different from the co-cultures (p=0.0519) (Appendix VII). 
In the untreated cultures (Fig. 17), ‘wound’ closure in the HaCaT cultures was 
significantly increased when compared to that of the co-cultures (p=0.0173) by 24 
hours post-wounding. In contrast, in the experiments using the vehicle control 
medium, there was an increase in score closure in the HaCaT cultures, but this was 
not significantly different when compared to that of the co-cultures over all 
experiment time points (Fig. 18).  
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Figure 16: A graphical illustration of ‘wound closure’ in response to ATRA treatment 
when HaCaT cultures were compared with co-cultures of HaCaT and HDF cells at 
different time periods. There was a significant difference in ‘wound’ closure when 
the cultures were compared by 10 hours after ‘wounding’ (n=12, *p<0.05). 
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Figure 17: A graphical illustration of ‘wound’ closure in untreated HaCaT cultures 
compared with untreated co-cultures of HaCaT and HDF cells at different time 
periods. ‘Wound’ closure was significantly different when the cultures were 
compared by 24 hours after ‘wounding’ (n=12, *p<0.05). 
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Figure 18: A graphical illustration of ‘wound’ closure in HaCaT cultures grown in 
vehicle control medium compared with co-cultures of HaCaT and HDF cells grown 
in a similar medium at different time periods. There was no statistically significant 
difference in ‘wound’ closure when the cultures at different time periods were 
compared (n=12). 
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3.5 Cell proliferation 
Ki-67 immuno-staining labels nuclei in the G1, S, G2 or mitotic phases of the cell 
cycle (Fisher et al., 2002; Potemski et al., 2006; Faratzis et al., 2009). Positively Ki-
67 immunolabelled nuclei were seen as darkly labeled nuclei in both the HaCaT 
cultures and the co-cultures (Fig. 19a1 - a2). No cells with immunolabelled nuclei 
were found when the Ki-67 primary antibody was omitted as a negative control (Fig. 
19b1 – b2). Representative photomicrographs of the HaCaT cultures and the co-
cultures immunolabelled with Ki-67 antibody for the different treatment groups at 
different time periods are depicted in Figure 20 and 21 respectively.  
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Figure 19: Photographic representations of HaCaT cultures and co-cultures of 
HaCaT and HDF cells immunolabelled with Ki-67 primary antibody. Photographs a1 - 
a2 represent the cultures with positive Ki-67 immunolabelled nuclei while b1 – b2 
represent the cultures in which the Ki-67 primary antibody was omitted (negative 
control). Phase contrast microscopy, X40. 
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Figure 20: Photographic representations of the HaCaT cultures immunolabelled with 
Ki-67 antibody (nuclei labelled dark brown) for the untreated cultures at 0 hour, 
cultures with ATRA treatment at 24 hours, untreated control cultures at 24 hours 
and cultures grown in vehicle control medium also at 24 hours. Phase contrast 
microscopy, X10. 
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Figure 21: Photographic representations of the co-cultures of HaCaT and HDF cells 
immunolabelled with Ki-67 antibody (nuclei labelled dark brown) for the untreated 
cultures at 0 hour, cultures with ATRA treatment at 24 hours, untreated control 
cultures at 24 hours and cultures grown in vehicle control medium at 24 hours. 
Phase contrast microscopy, X10. 
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3.5.1 Effect of ATRA on the number of actively proliferating HaCaT cells 
There was no statistically significant difference in the two independent counts of the 
number of actively proliferating cells in each of the samples (Appendix VIII) for 0 
hour and 24 hours under the different treatment regimes (ATRA treatment, vehicle 
control and untreated control). 
When the number of actively proliferating cells around the ‘wound’ region in the 
untreated HaCaT cultures (Appendix IX) at 0 hour was compared to the HaCaT 
cultures treated with ATRA (p=0.0026) at 24 hours or the HaCaT cultures grown in 
vehicle control medium (p=0.0018) at 24 hours (Fig. 22), there was a statistically 
significant increase in the number of proliferating cells. Despite a slight increase in 
the number of actively proliferating cells, there was no significant difference when 
the untreated HaCaT cultures at 0 hour was compared to the untreated HaCaT 
cultures at 24 hours (p=0.0555). 
At 24 hours (Fig. 22), the number of actively proliferating cells around the ‘wound’ 
region in the HaCaT cultures treated with ATRA was not significantly different when 
compared to the untreated control cultures (p=0.2423) or cultures grown in vehicle 
control medium (p=0.8174). In addition, there was no significant difference in the 
number of actively proliferating cells in the untreated control cultures when 
compared with the cultures grown in vehicle control medium (p=0.1113). 
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Figure 22: A graphical illustration of the number of actively proliferating HaCaT cells 
at 0 hour and at 24 hours under different treatment regimes. The number of actively 
proliferating cells significantly increased from 0 hour to 24 hours in the ATRA 
treated and in the vehicle control cultures. There was no significant difference in the 
number of actively proliferating cells in the HaCaT cultures at 24 hours under the 
three treatment regimes (n=4, **p<0.01). 
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3.5.2 Effect of ATRA on the number of actively proliferating cells in the co-
cultures 
There was no statistically significant difference in the two independent counts of the 
number of actively proliferating cells in each of the samples (Appendix VIII) for 0 
hour and 24 hours (for the ATRA treatment, vehicle control and untreated control). 
There was a statistically significant increase in the number of actively proliferating 
cells around the ‘wound’ region in the untreated co-cultures at 0 hour when 
compared with the co-cultures treated with ATRA (p=1.27E-07) at 24 hours or the 
untreated co-cultures (p=0.0036) at 24 hours or the co-cultures grown in vehicle 
control medium (p=3.67E-09) at 24 hours (Appendix X).  
At 24 hours (Fig. 23), there was a decrease in the number of actively proliferating 
cells around the ‘wound’ region in the co-cultures treated with ATRA when 
compared to the untreated control but this decrease was not significantly different 
(p=0.6033). However, there was a significant decrease in the number of actively 
proliferating cells in the co-cultures grown in the vehicle control medium when 
compared to the co-cultures treated with ATRA or the untreated co-cultures 
(p=0.0020 or p=2.11E-05 respectively). 
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Figure 23: A graphical illustration of the number of actively proliferating cells in the 
co-cultures of HaCaT and HDF cells under different treatment regimes at 0 hour and 
24 hours. The number of actively proliferating cells was significantly increased from 
0 hour to 24 hours. The number of actively proliferating cells was significantly 
different when the ATRA treatment and the vehicle control or the untreated control 
and the vehicle control were compared at 24 hours after the start of the experiment 
(n=4, **p<0.01). 
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3.5.3 Comparison of numbers of actively proliferating cells in the HaCaT 
cultures with the co-cultures 
There was no significant difference in the number of actively proliferating cells when 
the untreated HaCaT cultures at 0 hour were compared to the untreated co-cultures 
also at 0 hour (p=0.3075) (Fig. 24).  
At 24 hours (Table 1 and Fig. 24), the number of actively proliferating cells in the 
HaCaT cultures with ATRA treatment was significantly different when compared to 
the co-cultures treated in a similar manner (p=0.0028). Similarly in the untreated 
cultures, there was a highly significant difference in the number of actively 
proliferating cells in the HaCaT cultures when compared to the co-cultures (p= 
2.75E-06). However, there was no significant difference in the number of actively 
proliferating cells when the HaCaT cultures grown in vehicle control medium was 
compared to the co-cultures grown in a similar medium (p=0.2961) (Appendix X). 
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Table 1: Number of actively proliferating cells in the HaCaT cultures at 0 hour and 24 hours compared with the co-cultures 
of HaCaT and HDF cells at the same time period 
Time period 0 hour 24 hours 
 
Untreated control ATRA treatment Untreated control Vehicle control 
HaCaT Co-culture HaCaT Co-culture HaCaT Co-culture HaCaT Co-culture 
Number of actively proliferating cells per 
culture 309.63 292.13 354.88 400.75 340.00 408.75 358.00 344.50 
Standard deviation of number of actively 
proliferating cells per culture  (X10) 5.94 6.24 3.04 3.27 2.06 2.82 1.65 3.58 
p-value 0.3075 0.0028 2.75E-06 0.2961 
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Figure 24: A graphical illustration of the comparison of the number of cells positive for 
Ki-67 immunolabelling in the HaCaT cultures and in the co-cultures of HaCaT and 
HDF cells at 0 hour and at 24 hours under different treatment regimes. The number of 
actively proliferating cells was significantly different when the HaCaT cultures and the 
co-cultures were compared for the ATRA treatment and the untreated control 
respectively at 24 hours (n=4, **p<0.01). 
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CHAPTER FOUR 
DISCUSSION 
The results of the present study showed that treatment of HaCaT cultures with 1μM 
ATRA or with the vehicle control (0.0015% DMSO in DMEM) did not have an effect 
on cell proliferation compared to untreated cultures (DMEM alone) as deduced by the 
colorimetric cell proliferation assay.  
The non-proliferative effect of ATRA on the HaCaT cultures is in accordance with the 
report by Weninger et al. (1998) which also demostrated that ATRA at concentrations 
of 1µM or less, had no effect on proliferative activity in primary human keratinocyte 
cells. Weninger et al. (1998) further demonstrated using manual cell counts and 
quantification of total cellular protein, that treatment of epidermoid carcinoma and 
HaCaT cell lines with ATRA did not affect cell proliferative activity. In addition, as in 
the present study, Weninger et al. (1998) also reported that 0.01% DMSO (used as 
the vehicle control) did not have an effect on cell proliferation in cultures of primary 
human keratinocytes, HaCaT and epidermoid carcinoma.  
In the HDF cell cultures, there was a noticeable, but not significant, inhibition in cell 
proliferation with the treatment of ATRA compared to the untreated control cultures. In 
addition, there was a significant decrease in cell proliferation in the cultures grown in 
vehicle control medium when compared to either the cultures treated with ATRA or 
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grown in DMEM alone. The non-proliferative effect of ATRA on the HDF cells in the 
present study is in contrast to reports (Nelson and Balian, 1984; Priestley, 1987) that 
demonstrated inhibited proliferation following treatment with 1μM ATRA of neonatal 
human dermal fibroblasts (Nelson and Balian, 1984), and fibroblasts cell cultures 
derived from normal human skin as well as from lesional and non-lesional skin of 
patients with psoriasis disease (Priestley, 1987).  
It appears as though different concentrations of ATRA may have different effects. 
Harper and Burgoon (1982) investigated the effects of ATRA on the proliferation of 
fibroblast-like cells derived from rabbit, swine and human skins in vitro. Their results 
on fibroblast-like human skin demonstrated that proliferation was increased at a 
concentration of 0.33µM and 3.3µM ATRA but was inhibited at 13.2µM. In the same 
study, it was reported that proliferation of fibroblast-like rabbit skin was inhibited at 
concentrations of 0.05µM and 0.5µM (Harper and Burgoon, 1982). In addition, it was 
found that the concentrations of ATRA which inhibited proliferation of rabbit fibroblast-
like cells had no effect on swine fibroblast-like cells, but promoted proliferation of 
fibroblast-like human skin (Harper and Burgoon, 1982). 
The results of the Ki-67 immunolabelling analysis showed that the number of actively 
proliferating cells in the HaCaT cultures and in the co-cultures treated with ATRA 
were not significantly different when compared to the respective cultures grown in 
untreated control medium. This is in accordance with the results of the colorimetric 
cell proliferative activity for the HaCaT and the HDF cell lines in the present study in 
which ATRA was found to have no effect on cell proliferation. Interestingly, Lee et al. 
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(2009) while studying the transcriptional changes in normal human keratinocytes 
indicated that 1µM ATRA significantly induced, and at the same time, suppressed 
genes which are associated with the regulation of cell proliferation. Lee et al. (2009) 
proceeded to verify the cell proliferative effect of ATRA by determining the number of 
cells in ATRA-treated cultures at 24 and 48 hours following treatment using a 
colorimetric cell proliferation assay. The results however, showed moderate cell 
proliferation at both 24 and 48 hours, but cell proliferation was significantly increased 
in the cultures treated with ATRA compared to the untreated cultures. Lee et al. 
(2009) concluded that ATRA promotes cell proliferation in the keratinocytes despite 
observing a simultaneous expression and suppression of genes associated with cell 
proliferation. However, no effect of ATRA on the HaCaT, the HDF cell lines or the co-
culture was found in the present study. 
The number of actively proliferating cells in the co-cultures grown in the vehicle 
control medium was statistically significantly decreased when compared to either the 
co-cultures treated with ATRA or grown in untreated control medium. However, no 
effect of the vehicle control was found in the HaCaT cultures when compared to either 
HaCaT cultures treated with ATRA or untreated control medium. The inhibitory effect 
of DMSO on the co-culture and its non-significance in the HaCaT culture as deduced 
by the Ki-67 immunolabelling assays are in accordance with the results of the 
colorimetric cell proliferation assay in which the DMSO was inhibitory to cell 
proliferation in the HDF cells while it had no effect on proliferation in the HaCaT cells. 
The reason for the difference in the proliferative effect of DMSO in the HDF cells, 
HaCaT cells and in the co-culture cannot be ascertained in the present study. 
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In light of the inhibitory effect of DMSO on cell proliferation of the HDF cell line and 
the co-culture, but no effect on the HaCaT cultures, it thus appeared that DMSO was 
only inhibitory to the HDF cells. However, as ATRA was found to have no effect on 
cell proliferation in the HaCaT cells, HDF cells or co-culture as demonstrated in the 
present study, it thus appears that DMSO may have compromised the effect of ATRA. 
Unfortunately, suitable reports in the literature for comparison of the effect of DMSO 
on cell proliferation in HaCaT and HDF cell lines as well as in the co-cultures were not 
found. However, DMSO was implicated in compromising the positive effect of ATRA 
(in DMSO) on the number of insulin cells in cultures of embryonic chick pancreatic 
buds (Kramer and Penny, 2003). The present study thus suggests that DMSO had no 
effect on cell proliferation during ‘wound’ closure of the HaCaT culture, but that it 
appears to be inhibitory to cell proliferation during ‘wound’ closure in the co-cultures. 
From the scratch ‘wound’ assays for both ‘cell migration’ and cell proliferation assays, 
it appeared that cells at the ‘wound’ edge of both the HaCaT cultures and the co-
cultures proliferated and/or migrated to close the ‘wound’. This is in accordance with 
the reports in the literature that cell proliferative and migratory phases during the 
process of wound healing overlap (Metcalfe and Ferguson, 2006; Sweitzer et al., 
2006; Dewor et al., 2007). Buth et al. (2007) while studying the effect of cathepsin B 
(an extracellular degradation protease which is essential for cell migration) on 
regeneration of scratch ‘wounds’ in cultures of human epidermal cells reported that 
both cell proliferation and migration contributed to ‘wound’ closure. In another study 
using quantitative analysis, Dewor et al. (2007) indicated that proliferation contributed 
to about two-thirds and cell migration to about one-third of the actual ‘wound’ closure 
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of scratch-wounded primary human dermal fibroblasts. In light of the contribution of 
both cell proliferation and migration during the process of wound healing, it is thus 
impossible to rule out one of such process during the regeneration or closure of a 
wound (Matsuura et al., 2007). 
In the present study, ‘cell migration’ in the HaCaT cultures and in the co-cultures was 
not statistically significantly different when the cultures treated with ATRA and the 
untreated control cultures were compared. The non-significant effect of ATRA on cell 
migration in the HaCaT cultures and in the co-cultures in the present study is in 
accordance with the report by Lee et al. (2005). It was demonstrated that ATRA had a 
slight inhibitory effect on cell migration in primary human keratinocytes which had 
been pretreated with mitomycin C in order to arrest the cell cycle prior to scratching 
(Lee et al., 2005). However, this inhibition of cell migration was not significant (Lee et 
al., 2005). In another study, Lee et al. (2009) reported that ATRA at a concentration of 
1µM induced (at 4 hours) and suppressed (at 24 and 72 hours) genes which are 
related to keratinocyte migration. It was suggested that the slight inhibition of cell 
migration as reported by Lee et al. (2005) could have been as a result of the down-
regulation of genes associated with cell migration at 24 and 72 hours (Lee et al., 
2009). 
There was a statistically significant difference in cell migration’ in both the HaCaT 
cultures (at 10 and 24 hours) and the co-cultures (at 24 hours) when the ATRA 
treatment was compared to the cultures grown in vehicle control medium. As a result 
of a non-significant effect of ATRA on ‘cell migration’ or ‘wound’ closure in either the 
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HaCaT culture or the co-culture, the present study implicates DMSO (diluent for 
ATRA) as confounding the results. Unfortunately, there were no reports in the 
literature on the effect of DMSO on ‘cell migration’ or score closure with which to 
compare the results of the present study. The present study thus suggests that ATRA 
may not have a significant effect on cell migration during closure of scratch ‘wounds’ 
in the HaCaT cultures or the co-cultures.  
It is interesting to find in the present study that ATRA had no significant effect on cell 
proliferation or cell migration. In a study of the molecular mechanisms through which 
ATRA regulates proliferation, it was reported that ATRA significantly stimulated the 
production of heparin-binding EGF-like growth factor (a stimulant of proliferation) in 
cultured normal human keratinocytes, organotypic culture of skin and in intact human 
skin (Stoll and Elder, 1998). In addition, it was found that ATRA promoted cellular 
interactions resulting in the release of stimulants for cell proliferation in cultures of 
skin cells (Stoll and Elder, 1998). The difference in the effect of ATRA on cell 
migration and proliferation in the present study compared to reports in the literature 
(Harper and Burgoon, 1982; Lee et al., 2005; Lee et al., 2009) could be attributed to 
the difference in the cell types. In addition, DMSO which is often used as a diluent of 
ATRA could also contribute to these contradictions as observed in the present study. 
On the other hand, it has been suggested that the contradictions in the reports of the 
effect of ATRA could be as a result of a complex sequence of actions which are not 
yet fully understood (Davies et al., 1988; Watson et al., 2004; Takami et al., 2005).  
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In addition, the exact sequence or outcome of the bio-molecular effects of ATRA 
during wound healing could be difficult to establish in in vitro or in in vivo systems. It is 
important to know that the cellular activities and release of growth factors, cytokines, 
hormones and the expression of receptors for these molecules are regulated by gene 
transcription within the cells (Takami et al., 2005; Arukwe and Nordbo, 2008) as well 
as a possible interaction from co-activators (Goyette et al., 2000; Lee et al., 2009). 
Under normal circumstances, it is expected that only the gene associated with a 
particular cellular activity in response to ATRA treatment should be expressed at any 
given time (Thanos and Maniatis, 1995; Lee et al. 2005; Metcalfe and Ferguson, 
2006) but this is rarely the case. Instead, it is possible that a number of other factors 
which are either directly or indirectly linked to ATRA are simultaneously expressed 
with the desired gene (Thanos and Maniatis, 1995; Lee et al., 2009). This thus leads 
to the expression of a multitude of genes associated with different cellular activities 
being expressed at the same time (Thanos and Maniatis, 1995; Lee et al., 2005; 
Metcalfe and Ferguson, 2006; Lee et al., 2009). Lee et al. (2009) while comparing 
genes which were regulated by ATRA at a concentration of 1μM with those induced 
by transforming growth factor-β (TGF-β) reported that several genes were regulated 
by TGF-β either in a similar manner or directly opposite to the effect of ATRA. It was 
stated that the co-activator (TGFβ) which was released by cells could augment or 
diminish the effect of ATRA (Lee et al., 2009) which could be a contributing factor to 
the contradictions in the reports on the effect of ATRA. This simultaneous sequence 
of events in multiple expressions of genes or activity of co-activators thus makes 
tracing the path and understanding the role of ATRA in wound healing difficult (Lee et 
al., 2005) either in an in vivo or in vitro system. 
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The present study found that cell migration was significantly increased in the HaCaT 
cultures grown in DMEM alone when compared to the co-cultures grown in the same 
medium. In the cultures treated with ATRA or cultures grown in vehicle control 
medium, cell migration was increased in the HaCaT cultures compared to the co-
cultures. However, the increase in cell migration was not statistically significant. It 
thus appears that the co-culturing of the HaCaT cell line with the HDF cell line could 
have possibly decreased ‘cell migration’ or ‘wound’ closure in the co-cultures due to 
its bi-cellularity.  
It is reasonable to state that the functionality of an in vitro skin system may not solely 
be dependent on the individual cell types in the cultures (Metcalfe and Ferguson, 
2006). The complex structural organization of the in vitro system and the complex 
biological interactions which exist between the cells could also play an important role 
in the functionality of an in vitro skin model (Wakatsuki et al., 2000; Grinnell, 2003). 
Apart from a possible influence of the bi-cellular nature of the co-cultures in the 
present study, it thus suggests that the decrease in migration in the co-cultures could 
be as a result of a complex interaction and/or the complexity arising from the in vitro 
condition.  
Rorth (2002) in a review of initiation and guidance of migration by border cells during 
Drosophilia oogenesis emphasized that obvious differences exist between cells 
‘crawling in a dish’ (in vitro) and cells migrating in vivo. These differences in the 
migration patterns could be attributed to difference in the resistance to movement 
within the two environments (Rorth, 2002). In his report, Rorth (2002) explained that 
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cells migrating in an in vivo environment encounter greater resistance caused by 
multifaceted cell-to-cell adhesions, complex biological interaction between cells, 
three-dimensional structural organization of the cells and multicellularity. It was 
emphasized that before cell migration can occur in vivo, these resistances have to be 
overcome, which thus requires “a strong protrusive force, traction and contraction” 
(Rorth, 2002). It is therefore the assumption of the present study that the layered 
nature and the bi-cellularity of the co-cultures mimicked certain characteristics of 
human skin. This was demonstrated by the decrease in cell migration in the co-
cultures compared to the HaCaT cultures as illustrated by Rorth, 2002. 
In addition, the number of actively proliferating cells in the co-cultures in the present 
study was greater than in the HaCaT cultures for the 24 hours treatment regime. It 
could be suggested that the increase in the number of actively proliferating cells in the 
co-culture may be due to the increased numbers of cells in the co-cultures (both 
HaCaT and HDF cells) compared to the HaCaT cultures. At the start of the 
experiment (0 hour) however, there was no statistically significant difference in the 
number of actively proliferating cells when the HaCaT cultures and the co-cultures 
were compared.  
The number of actively proliferating cells in the co-cultures either treated with ATRA 
or grown in DMEM alone was significantly higher when compared to the HaCaT 
cultures cultured in a similar manner 24 hours after the start of the experiment. It thus 
appeared that cell proliferation around the ‘wound’ region was greater in the co-
cultures when compared with the HaCaT cultures. Biological interaction between skin 
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cells have been reported to influence or promote the process of wound healing (Stoll 
and Elder, 1998; Metcalfe and Ferguson, 2006). Evidence has also shown that 
keratinocytes and fibroblasts secrete numerous growth factors (Boyce et al., 1996) 
such as transforming growth factor-α and basic fibroblast growth factor which have 
been reported to facilitate the process of wound healing (Root and Shipley, 1991; 
Boyce et al., 1996; Metcalfe and Ferguson, 2006). It thus suggests that cell 
proliferation could have been promoted in the co-cultures in the present study due to 
a possible complex cellular interaction between its two cell types compared to the 
HaCaT culture which contained only one cell type. The possibility of complex cellular 
interaction in the co-culture as deduced by comparison of the number of actively 
proliferating cells in the HaCaT culture with the co-culture further supports the 
assumption of the present study that the co-culture mimicked certain characteristic of 
human skin. 
It is important to re-emphasize that the complete recreation of skin in vitro has not 
been achieved (Lim et al., 2002; Boyce and Waden, 2002; Suhonen et al., 2003; 
Maas-Szabowski et al., 2004; Metcalfe and Ferguson, 2006) and neither has 
vascularization of the skin been achieved in vitro (Metcalfe and Ferguson, 2006). 
Although a porous acellular-glycoaminoglycan matrix (extracellular matrix) was not 
used in the co-culture in the present study, there are convincing reports in the 
literature that fibroblasts secrete extracellular matrix such as collagen type I, in vitro 
(Hata and Senoo, 1989; Ohgoda et al., 1998; Moulin et al., 2000; Maas-Szabowski et 
al., 2004; Lee et al., 2006). The ability of fibroblasts to secrete extracellular matrix 
was similarly reported by Lee et al. (2006) in which a confluent culture of human 
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dermal fibroblasts was used as a dermal equivalent in developing an organ culture of 
skin. In addition, it was reported that a HaCaT cell line used in a scratch-wound assay 
synthesized collagen type IV which is a constituent of dermal skin (Buth et al., 2007). 
In light of a possible existence of a complex cellular interaction and the bi-cellular 
nature as well as complex adhesion in the co-cultures in the present study, it 
suggests that the co-culture mimics or simulates the complex biological interactions 
and the multicellular nature of intact human skin.  
CONCLUSION 
The present study found that ATRA had no effect on cell proliferation in either of the 
individual cell lines used in this study or in the co-cultures. The DMSO (vehicle 
control) inhibited proliferation of the HDF cells as well as the co-cultures but did not 
appear to have an effect on the HaCaT cultures. It thus seems that the inhibitory 
effect of DMSO on proliferation appears to be directed towards the HDF cells as well 
as the co-cultures which contained HDF cells. ATRA also did not have an effect on 
‘migration’ of cells in the HaCaT cultures or the co-cultures during ‘wound’ closure. In 
light of the failure of ATRA to promote ‘cell migration’ and proliferation during wound 
closure of the HaCaT culture and the co-cultures in the present study, it would seem 
that the activity of ATRA was compromised in the presence of DMSO. This may also 
substantiate why there is controversy in the literature regarding the effect of ATRA, as 
DMSO is often the diluent for ATRA. It is recommended that the exploration of the 
effect of ATRA at this particular concentration (1μM) without the use of the diluent 
(DMSO) would be beneficial in understanding the true effect of ATRA. 
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In future studies, it would be interesting to investigate the wound healing capabilities 
of ATRA on primary cultures derived from human skin to determine whether 
differences exist. In addition, an in vivo study on the effect of ATRA needs to be 
performed to ascertain its possible effect during wound healing, which would 
complement the findings of the present study. It would also be beneficial to 
investigate whether ATRA would express or suppress certain genes which are 
associated with cell proliferation and migration during wound healing in either an in 
vitro or in vivo situation.     
As a result of a slowed ‘migration’ of cells in the co-culture compared to the HaCaT 
culture as demonstrated in the present study, it is believed that the co-culture more 
closely mimicked certain biological characteristics peculiar to intact skin. The present 
study thus recommends its use as a model of human skin for studies on scratch-
wound assays. 
 
 
 
 
 
 
77 
 
APPENDIX  
I 
Preparation of 1µM ATRA 
The preparation of serial dilutions of ATRA from the stock solution was performed as 
follows: 
- 100mg of ATRA powder was dissolved in 5ml 100% DMSO 
  Molecular formula of ATRA= 300.44 
  ATRA concentration =        mass     
       Volume X Molecular mass  
 
       =  100mg  
            5ml X 300.44 
     =  0.0666M or 66600µM 
Using dilution formula (C1V1=C2V2) the ATRA stock solution was diluted in the culture 
medium to 10000µM ATRA  
 Where C1 = 66600µM; V1 = unknown; C2 = 10000µM and V2 = 1000µL 
The volume of stock solution  =  10000 X 1000 
            66600 
 
     = 150.15µL 
 
Therefore 150.15µL of ATRA stock solution was dissolved in 849.85µL of culture 
medium to prepare 10000µM ATRA.  
78 
 
Using a dilution factor of 10, the concentration of 10000µM ATRA was further diluted 
four times i.e. to 1000µM, 100µM, 10 µM and finally to 1µM (desired concentration). 
In the same manner as the preparation of 1µM ATRA, serial dilutions of DMSO from 
stock solution (100% DMSO) were performed exactly in the same order as the 
preparation of 1µM ATRA. 
Using dilution formula, C1V1=C2V2 
 Where C1 = 100%; V1 = 150.15μL; C2 = unknown and V2 = 1000µL 
Concentration of DMSO  =  100 X 150.15 
           1000 
 
     = 15.15% 
Using a dilution factor of 10, the concentration of DMSO was diluted four times 
(equivalent to the number of times ATRA was diluted in preparing 1μM ATRA) to a 
final concentration of 0.0015%. 
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II 
Counting of cells using a haemocytometer chamber 
From a confluent culture in a 25ml Nunc® culture flask, 
- 1ml of trypsinized cells was suspended in 4ml culture medium 
- 20µl of this cell suspension was mixed with an equal volume of 0.4% trypan 
blue (a dilution factor of 2) and then mixed thoroughly 
- Using a pipette, 20µl of this suspension was carefully placed into the two 
compartments of a clean and dry hemocytometer chamber  
- Only the viable cells (clear cells) within the five squares were counted 
- The average of two counted cells was used 
Using the formula below,  
Cells per ml   =  average cell count per square X dilution factor X 104 
For example, if average of 58 cells were counted from 5 squares 
Then, cells per ml =  44 X 2 X 104  
               5 
  = 1.76 X 105 cells per ml 
The desired cell concentration was obtained by diluting the cell suspension. 
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III 
Preparation of calcium and magnesium-free phosphate buffered saline (CMF-PBS) 
The following salts were into 1 litre de-ionized water:  
NaCl   8.77g 
 Na2HPO4  1.15g 
 KCl   0.20g 
  KH2PO4  0.18g 
 
The pH of the solution was adjusted to 7.4 by adding 1M NaOH. The solution was 
then sterilized and stored in 4ºC. 
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IV 
Preparation of reagents for immunocytochemistry 
i. Phosphate buffered saline (PBS) 
The following salts were added into 1 litre de-ionized water  
 NaCl   8.00g 
 Na2HPO4  1.15g 
 KCl   0.20g 
  KH2PO4  0.20g 
The pH was adjusted to 7.4 by adding 1M NaOH and stored in 4ºC. 
ii. Tris-Buffered Saline (TBS) 
The following salts were added into 1 litre de-ionized water  
 TRIS-BASE  6.055g 
 NaCl   8.766g 
The pH was adjusted to 7.4 by adding 1M NaOH and stored in 4ºC. 
iii. Diaminobenzidine tetrahydrochloride (DAB) reagent 
7µl of 30% H2O2 was added into 10 ml water 
1mg/ml DAB was added into 10ml PBS 
The two solutions were prepared prior to use. The two solutions were then mixed 
together and filtered with a filter paper. 
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V 
Statistical tests for colorimetric cell proliferation assays 
Depend: 
Cell proliferation 
  
Statistical test: HaCaT cell line proliferation assay 
Independent (grouping) variable:  
ATRA treatment; Untreated control; Vehicle control 
Kruskal-Wallis test: (3, n= 6) p =0.2811 
  ATRA treatment Untreated control Vehicle control 
ATRA treatment 0 0.2980 0.1735 
Untreated control 0.8939 0 1 
Vehicle control 0.5205 0.8102 0 
 
Depend: 
Cell proliferation 
Statistical test: HDF cell line proliferation assay 
Independent (grouping) variable:  
ATRA treatment; Untreated control; Vehicle control 
Kruskal-Wallis test: (3, n= 6) p =0.002005 
  ATRA treatment Untreated control Vehicle control 
ATRA 0 0.1495 0.0051 
Untreated control 0.4486 0 0.0051 
Vehicle control 0.0152 0.01522 0 
 
 
83 
 
VI 
Statistical tests for ‘wound’ closure analyses 
Depend: 
Wound closure 
HaCaT cultures 
Independent (grouping) variable:  
ATRA treatment; Untreated control; Vehicle control 
Kruskal-Wallis test: (3, n=12) 
2 hour (p=0.4941) 
ATRA treatment Untreated control Vehicle control 
ATRA treatment 0 0.3708 0.2855 
Untreated control 1 0 0.8852 
Vehicle control 0.8564 0.0152 0 
4 hours (p=0.8554) 
ATRA treatment Untreated control Vehicle control 
ATRA treatment 0 0.8399 0.6650 
Untreated control 1 0 0.6650 
Vehicle control 1 1 0 
6 hours (p=0.4472) 
ATRA treatment Untreated control Vehicle control 
ATRA treatment 0 0.7075 0.2366 
Untreated control 1 0 0.4025 
Vehicle control 0.7098 1 0 
8 hours (p=0.2103) 
ATRA treatment Untreated control Vehicle control 
ATRA treatment 0 0.5067 0.0689 
Untreated control 1 0 0.4025 
Vehicle control 0.2069 1 0 
10 hours (p=0.0576) 
ATRA treatment Untreated control Vehicle control 
ATRA treatment 0 0.2145 0.0166 
Untreated control 0.6435 0 0.3408 
Vehicle control 0.0497 1 0 
24 hours (p=0.1134) 
ATRA treatment Untreated control Vehicle control 
ATRA treatment 0 0.9770 0.0404 
Untreated control 1 0 0.141 
Vehicle control 0.1212 0.4229 0 
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Depend: 
Wound closure 
 
Co-cultures 
Independent (grouping) variable:  
ATRA treatment; Untreated control; Vehicle control 
Kruskal-Wallis test: (3, n=12) 
2 hour (p=0.1970) 
ATRA treatment Untreated control Vehicle control 
ATRA treatment 0 0.5834 0.0689 
Untreated control 1 0 0.3123 
Vehicle control 0.2069 0.9370 0 
4 hours (p=0.9340) 
ATRA treatment Untreated control Vehicle control 
ATRA treatment 0 0.7508 0.7950 
Untreated control 1 0 0.9770 
Vehicle control 1 1 0 
6 hours (p=0.3863) 
ATRA treatment Untreated control Vehicle control 
ATRA treatment 0 0.2602 0.2366 
Untreated control 0.7807 0 0.8852 
Vehicle control 0.7098 1 0 
8 hours (p=0.2895) 
ATRA treatment Untreated control Vehicle control 
ATRA treatment 0 0.2855 0.1260 
Untreated control 0.8564 0 0.8399 
Vehicle control 0.3781 1 0 
10 hours (p=0.3036) 
ATRA treatment Untreated control Vehicle control 
ATRA treatment 0 0.2145 0.1749 
Untreated control 0.6435 0 0.9770 
Vehicle control 0.5246 1 0 
24 hours (p=0.0425) 
ATRA treatment Untreated control Vehicle control 
ATRA treatment 0 0.0531 0.0226 
Untreated control 0.1593 0 0.7075 
Vehicle control 0.06773 1 0 
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VII 
Statistical test of the comparison of ‘wound’ closure between the HaCaT cultures and 
the co-cultures 
Depend: 
Wound 
closure 
  
HaCaT cultures versus co-cultures 
Independent (grouping) variable: HaCaT Vs. Co-culture  
Mann-Whitney test: (2, n=12) 
  ATRA treatment 
Group Sample 
Mean rank 
(HaCaT) 
Mean rank (co-
culture) p value U 
exact 
p value 
2 hours 12 6.417 6.083 0.8399 68 0.8428 
4 hours 12 5.958 6.542 0.7075 65 0.7125 
6 hours 12 6.708 5.792 0.5444 61 0.5512 
8 hours 12 7.542 4.958 0.0782 41 0.0780 
10 hours 12 7.958 4.542 0.0194 31 0.0173 
24 hours 12 7.667 4.833 0.0531 38 0.0519 
Untreated control 
Group Sample 
Mean rank 
(HaCaT) 
Mean rank (co-
culture) p value U exact p value 
2 hours 12 6.417 6.083 0.8399 68 0.8428 
4 hours 12 5.958 6.542 0.7075 65 0.7125 
6 hours 12 7.083 5.417 0.2602 52 0.2657 
8 hours 12 7.542 4.958 0.0783 41 0.0780 
10 hours 12 7.333 5.167 0.1410 46 0.1432 
24 hours 12 7.958 4.542 0.0194 31 0.0173 
Vehicle control 
Group Sample 
Mean rank 
(HaCaT) 
Mean rank (co-
culture) p value U exact p value 
2 hours 12 6.042 6.458 0.7950 67 0.7987 
4 hours 12 5.833 6.667 0.5834 62 0.5899 
6 hours 12 6.208 6.292 0.9770 71 0.9774 
8 hours 12 7.167 5.333 0.2145 50 0.2189 
10 hours 12 7.083 5.417 0.2602 52 0.2657 
24 hours 12 7.417 5.083 0.1124 44 0.1135 
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VIII 
Statistical test of the comparison between two independent counts of actively 
proliferating cells in the HaCaT cultures and the co-cultures 
Depend:  
Cell proliferation 
(Ki-67 
immunolabelling) 
HaCaT cultures 
Independent (grouping) variable: Count 1 versus count 2 
Mann-Whitney test (2, n=4) 
Group Sample 
Mean rank 
(count 1) 
Mean rank 
(count 2) p value U 
Exact 
p value 
Untreated control 
(0 hour) 40 20.40 20.10 0.9089 788.0 0.9117 
ATRA treatment 
(24 hours) 40 19.79 20.71 0.7325 763.5 0.7284 
Untreated control 
(24 hours) 40 19.79 20.71 0.7191 763.5 0.7286 
Vehicle control 
(24 hours) 40 21.09 19.41 0.5169 733.0 0.5212 
 
Depend:  
Cell proliferation 
(Ki-67 
immunolabelling) 
Co-cultures 
Independent (grouping) variable: Count 1 versus count 2 
Mann-Whitney test (2, n=4) 
Group Sample 
Mean rank 
(count 1) 
Mean rank 
(count 2) p value U 
exact p 
value 
Untreated control 
(0 hour) 40 20.06 20.44 0.8897 785.0 0.8889 
ATRA treatment 
(24 hours) 40 20.10 20.40 0.9109 788.0 0.9118 
Untreated control 
(24 hours) 40 19.02 21.48 0.3440 701.5 0.3447 
Vehicle control 
(24 hours) 40 19.72 20.78 0.6842 757.5 0.6856 
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IX 
Statistical tests for the number of actively proliferating cells in the HaCaT cultures and 
the co-cultures 
Depend:  
Cell proliferation 
(Ki-67 
immunolabelling) 
HaCaT cultures 
Independent (grouping) variable:  
Untreated control (0 hour); ATRA treatment; Untreated 
control; Vehicle control 
Kruskal-Wallis test (4, n=4) 
Untreated 
control 
(0 hour) 
ATRA 
treatment 
(24 hours) 
Untreated 
control  
(24 hours) 
Vehicle 
control  
(24 hours) 
Untreated control 
(0 hour) 0 0.0026 0.0555 0.0018 
ATRA treatment 
(24 hours) 0.0158 0 0.2423 0.8174 
Untreated control 
(24 hours) 0.3330 1 0 0.1113 
Vehicle control  
(24 hours) 0.0108 1 0.6676 0 
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Depend:  
Cell proliferation 
  
Co-cultures 
Independent (grouping) variable:  
Untreated control (0 hour); ATRA treatment; Untreated 
control, Vehicle control 
Kruskal-Wallis test (4, n=4)  
Untreated 
control  
0 hour 
ATRA 
treatment 
(24 hours) 
Untreated 
control  
(24 hours) 
Vehicle 
control  
(24 hours) 
Untreated control  
(0 hour) 0 1.27E-07 3.67E-09 0.0036 
ATRA treatment  
(24 hours) 7.64E-07 0 0.6033 0.0020 
Untreated control 
(24 hours) 2.20E-08 1 0 2.11E-05 
Vehicle control  
(24 hours) 0.0216 0.0059 0.0001 0 
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X 
Statistical test of the comparison of the number of actively proliferating cells between 
the HaCaT cultures and the co-cultures 
Depend:  
Cell proliferation 
  
HaCaT cultures versus Co-cultures 
Independent (grouping) variable: Hacat cultures; co-cultures 
Mann-Whitney test (4, n=4) 
Group Sample 
Mean rank 
(HaCaT) 
Mean rank 
(Co-culture) p value U 
exact p 
value 
Untreated control 
(0 hour) 40 21.58 18.92 0.3051 693.5 0.3075 
ATRA treatment 
(24 hours) 40 16.36 24.14 0.0024 489.0 0.0028 
Untreated control  
(24 hours) 40 14.16 26.34 0.0001 312.5 2.75E-06 
Vehicle control 
(24 hours) 40 21.61 18.89 0.2972 691.0 0.2961 
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